Pappas Capital

What is Pappas Capital?

Pappas Capital is a seasoned venture capital firm headquartered in Durham, North Carolina, with a sharp focus on the life sciences sector. They have a long-standing presence of over 30 years in the investment landscape.

The firm primarily pours capital into companies based in the United States and Canada, specializing in areas such as life sciences, biotechnology, biopharmaceuticals, drug delivery, and medical devices. With a specialty in seed-stage investments, Pappas Capital endeavors to support the inception and growth of pioneering enterprises that are capable of developing the next generation of life science products and technologies.

They boast a portfolio of more than 90 companies stretched across the United States, Canada, and Asia, targeting a wide spectrum of human diseases.

The investment reach of Pappas Capital is substantial, with their portfolio companies contributing to various medical fields, including melanoma, ovarian cancer, and hemophilia, among others. The firms' undertakings have had a global impact, with products reaching worldwide markets, aiding thousands of patients and generating considerable revenue.

Pappas Capital positions itself not only as a source of capital but also as a partner providing specialized fund management across initiatives such as the Chiesi Ventures Fund, Asia Innovation Ventures, AgTech Initiatives, and engaging in specialized holdings and translational medicine.

Their team consists of experienced investment professionals dedicated to the success of their portfolio companies. Pappas Capital extends its expertise not only to companies seeking investment but also to those with capital to invest or looking for growth opportunities.

By highlighting their history and forward-looking approach, Pappas Capital illustrates a deep commitment to advancing life science breakthroughs and achieving positive results for investors and the industry at large.